Literature DB >> 12231108

Effect of sildenafil on the acute pulmonary vasodilator response to inhaled nitric oxide in adults with primary pulmonary hypertension.

John J Lepore1, Anjli Maroo, Naveen L Pereira, Leo C Ginns, G William Dec, Warren M Zapol, Kenneth D Bloch, Marc J Semigran.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12231108     DOI： 10.1016/s0002-9149(02)02586-9

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  25 in total

1.  Sildenafil versus nitric oxide for acute vasodilator testing in pulmonary arterial hypertension.

Authors:  Katrin Milger; Janine F Felix; Robert Voswinckel; Natascha Sommer; Oscar H Franco; Friedrich Grimminger; Frank Reichenberger; Werner Seeger; Hossein A Ghofrani; Henning Gall
Journal:  Pulm Circ       Date:  2015-06       Impact factor: 3.017

Review 2.  [Treatment of acute and chronic right ventricular failure].

Authors:  T Kramm; S Guth; C B Wiedenroth; H A Ghofrani; E Mayer
Journal:  Med Klin Intensivmed Notfmed       Date:  2016-05-30       Impact factor: 0.840

3.  Sildenafil citrate and sildenafil nitrate (NCX 911) are potent inhibitors of superoxide formation and gp91phox expression in porcine pulmonary artery endothelial cells.

Authors:  Saima Muzaffar; Nilima Shukla; Amit Srivastava; Gianni D Angelini; Jamie Y Jeremy
Journal:  Br J Pharmacol       Date:  2005-09       Impact factor: 8.739

Review 4.  Type 5 phosphodiesterase inhibition in heart failure and pulmonary hypertension.

Authors:  Gregory D Lewis; Marc J Semigran
Journal:  Curr Heart Fail Rep       Date:  2004-12

Review 5.  Phosphodiesterase 5 inhibition in heart failure: mechanisms and clinical implications.

Authors:  Praneet Kumar; Gary S Francis; W H Wilson Tang
Journal:  Nat Rev Cardiol       Date:  2009-05       Impact factor: 32.419

Review 6.  Pulmonary hypertension: current diagnosis and treatment.

Authors:  Stephan Rosenkranz
Journal:  Clin Res Cardiol       Date:  2007-06-04       Impact factor: 5.460

Review 7.  Evolving Concepts of Pulmonary Hypertension Secondary to Left Heart Disease.

Authors:  Bhavadharini Ramu; Thenappan Thenappan
Journal:  Curr Heart Fail Rep       Date:  2016-04

Review 8.  Erectile dysfunction in the cardiac patient.

Authors:  Robert A Kloner
Journal:  Curr Urol Rep       Date:  2003-12       Impact factor: 3.092

Review 9.  Sildenafil: a review of its use in pulmonary arterial hypertension.

Authors:  Katherine F Croom; Monique P Curran
Journal:  Drugs       Date:  2008       Impact factor: 9.546

Review 10.  Inhaled NO as a therapeutic agent.

Authors:  Kenneth D Bloch; Fumito Ichinose; Jesse D Roberts; Warren M Zapol
Journal:  Cardiovasc Res       Date:  2007-05-04       Impact factor: 10.787
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.